Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Thermal Biosensor Market to Reach $11.4 Billion, Globally, by 2032 at 8.5% CAGR…
Download Research Report Sample & TOC: Download Research Report Sample & TOC: https://www.alliedmarketresearch.com/request-sample/274296 (We look forward to moving quickly provide the report analysis as per your research requirement, needed for your business success.) Prime Determinants of Growth The thermal biosensor market is expected to witness notable growth during the forecast period, owing to increase in requirement of healthcare diagnosis, rise in emphasis on...
PR Newswire
28/11/2023
Non-Invasive Aesthetic Treatment Market to Reach $37.4 Billion, Globally, by…
Request Sample of the Report on Non-Invasive Aesthetic Treatment Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/210858 Request Sample of the Report on Non-Invasive Aesthetic Treatment Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/210858 Prime determinants of growth Growing R&D activities, rise in adoption, and growing awareness regarding the availability of various noninvasive aesthetic procedures are the factors that...
PR Newswire
28/11/2023
Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life…
Earlier this year, driven by the country's strong commitment to scientific research and development, as well as its regulatory environment that supports a culture of innovation, Flagship began growing its presence in London and established an office, its first such office outside the United States. Located in London, the new office will serve as a regional hub for Flagship's operations in the UK, and into Europe. Earlier this year, driven by the country's strong commitment to scientific...
PR Newswire
28/11/2023
Groupe Casino: Update of Casino supermarket and hypermarket current trading
Update of Casino supermarket and hypermarket current tradingParis, 27 November 2023Casino Group has today published apresentationon its website relating to the update of the current trading of its supermarkets and hypermarkets.***This press release was prepared solely for information purposes and should not be construed as a solicitation or an offer to buy or sell securities or related financial instruments. Likewise, it does not provide and should not be treated as...
Nasdaq GlobeNewswire
27/11/2023
Edge Computing in Healthcare Market Expected to Cross USD 43.29 Billion By 2032…
What is the use of Edge Computing in Healthcare? How Big is Edge Computing in Healthcare Market Size? What is the use of Edge Computing in Healthcare? How Big is Edge Computing in Healthcare Market Size? The process of bringing computer power and data processing devices closer to the sources of medical data so they can be examined more quickly in order to save lives and enhance patient outcomes is known as edge computing in the healthcare industry. Edge devices handle data from asset...
PR Newswire
27/11/2023
Restorative Dentistry Market Worth $7.4 Billion | MarketsandMarkets
Browse in-depth TOC on "Restorative Dentistry Market" Browse in-depth TOC on "Restorative Dentistry Market" 339 - Tables 50 - Figures 322 - Pages Restorative Dentistry Market Scope: Based on the product segment, the material segment holds the major share of the restorative dentistry market in 2022. Based on product, the restorative dentistry monitoring devices market is segmented into materials, equipments and instruments. The materials segment accounted for the...
PR Newswire
27/11/2023
Dental 3D Printing Market Revenue to Cross USD 16 billion by 2035, Registering…
The global dental 3D printing market size was estimated at USD 2.9 billion in 2023 and is expected to reach over USD 16 billion by 2035, at a compounded annual growth rate (CAGR) of 15.1% in the forecast period 2023- 2035. The global dental 3D printing market size was estimated atUSD 2.9 billionin 2023 and is expected to reach overUSD 16 billionby 2035, at a compounded annual growth rate (CAGR) of 15.1% in the forecast period 2023- 2035. 3D printing is a form of printing...
PR Newswire
27/11/2023
International Bladder Cancer Group (IBCG) and UroToday Announce Formal…
The IBCG is a globally recognized organization dedicated to improving the care of patients with bladder cancer through critical evaluation and leveraging of existing data to drive evidence-based treatment. UroToday is a leading provider of urology news and education, reaching over 500,000 urologists and healthcare professionals worldwide. The IBCG is a globally recognized organization dedicated to improving the care of patients with bladder cancer through critical evaluation and leveraging of...
PR Newswire
27/11/2023
AIM ImmunoTech Bolsters Intellectual Property Estate for Ampligen® with Issuance…
Extends certain exclusive U.S. rights to Ampligen for cancer and ME/CFS through 2039 Management discusses patent issuance and what this means in a brief video: hereOCALA, Fla., Nov.27, 2023(GLOBE NEWSWIRE) -- AIM ImmunoTech Inc.(NYSE American: AIM) (“AIM” or the “Company”) today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. patent No. 11,813,279 and 11,813,281 for Ampligen ®titled “ Compositions for cancer therapy and methods,”and “...
Nasdaq GlobeNewswire
27/11/2023
Novo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 27 November 2023– On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 30 billion to be executed during a 12-month period beginning 1 February 2023. Under…
Nasdaq GlobeNewswire
27/11/2023
Philips launches HealthSuite Imaging, a cloud-based next generation of Vue PACS…
Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its enterprise imaging portfolio and AI-enabled solutions at #RSNA23 . Philips HealthSuite Imaging is a next generation cloud-based PACS enabling radiologists and clinicians to adopt new capabilities faster, help improve operational efficiency and enhance patient care. HealthSuite Imaging on Amazon Web Services (AWS) offers new...
Nasdaq GlobeNewswire
27/11/2023
KFSH&RC Jeddah Hosts The 10th International Nursing Conference Gathering…
- Honorary Accreditation of the Nursing Residency Program announced Marking its first edition post the COVID-19 pandemic era, this year's conference, spanning three days, features a lineup of 14 keynote sessions, 40 concurrent sessions, 10 in-depth workshops, and 55 simultaneous presentations. The expected attendance is around 650 individuals.In a significant announcement at today's conference, the Nursing Residency Program at Jeddah's King Faisal Specialist Hospital and Research Center...
Nasdaq GlobeNewswire
27/11/2023
deepc Establishes MONAI Compatibility, Strengthening Its Commitment to…
deepc also joins the MONAI Deploy working group to actively shape standards for medical imaging AI. Its dedicated contributions to MONAI positions deepc as a strategic partner for university hospitals in medical AI research, offering crucial support in AI development and deployment. deepc also joins the MONAI Deploy working group to actively shape standards for medical imaging AI. Its dedicated contributions to MONAI positions deepc as a strategic partner for university hospitals in medical…
PR Newswire
27/11/2023
Philips improves workflow and efficiency with next generation ultrasound systems…
Improved imaging and advanced tools drive standardized workflow efficiency across multiple specialtiesShared common interface and transducers let users move effortlessly between ultrasound systems for a more simplified user experience Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today placed workflow and efficiency at the heart of the next generation of its flagship ultrasound systems EPIQ Elite...
Nasdaq GlobeNewswire
27/11/2023
Octapharma to present new clinical and scientific data at ASH 2023 from ongoing…
The WIL-31 study investigated the efficacy and safety of prophylaxis with wilate® in adults and children of any gender with all types of VWD. WIL-31 is the largest prospective prophylaxis study in VWD and the only one with a prospective on-demand run-in study as an intra-individual comparator. The results of the study showed that wilate® prophylaxis is highly effective at reducing the number of bleeds in children and adults and provides compelling evidence to support the use of regular…
PR Newswire
27/11/2023
IM Cannabis Announces Receipt of Court Action
IMC has reviewed the complaint and believes that the allegations are without merit. IMC plans to vigorously defend itself against the allegations. IMC's policy is not to discuss pending litigation. IMC has reviewed the complaint and believes that the allegations are without merit. IMC plans to vigorously defend itself against the allegations. IMC's policy is not to discuss pending litigation. About IM Cannabis Corp. IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company...
PR Newswire
27/11/2023
Amorphical brings Scientific Breakthrough - Treating and Curing Chronic…
Amorphical has developed a pioneering technology to produce amorphous nano-minerals. Amorphical has developed a pioneering technology to produce amorphous nano-minerals. The unique structure of these amorphous nano-minerals enables the efficient and rapid absorption of essential minerals in the body. Amorphous nano-minerals also possess a unique ability to stimulate healing mechanisms within the target damaged tissues. Amorphous Calcium Carbonate – Amorphical's Revolutionary Leading...
PR Newswire
27/11/2023
Luxury Furniture Market Size to Reach USD 38.9 billion, at a 5.2% CAGR by 2031 |…
Rising demand from the real estate industry as well as increasing urban population in various emerging economies around the world are some of the major factors contributing to the growth and advancement of the global luxury furniture market. Rising demand from the real estate industry as well as increasing urban population in various emerging economies around the world are some of the major factors contributing to the growth and advancement of the global luxury furniture market. Request to...
PR Newswire
27/11/2023
NOSTER Research: Gut bacteria derived metabolites offer alternative treatment…
Notably, pioglitazone is a diabetes medication that has shown some signs of improvement in NAFLD. However, the mechanism by which it does so is unclear. In a recent collaboration across institutes in Japan, a team led by Tetsuya Hosooka from Shizuoka University and including researchers from Noster Inc, has shown the pathways pioglitazone modifies in order to achieve this effect. Notably, pioglitazone is a diabetes medication that has shown some signs of improvement in NAFLD. However, the...
PR Newswire
27/11/2023
Today Essity holds the webcast - Innovating for profitable and sustainable…
Agenda: Agenda: Link to the webcast:https://event.vvenues.com/essity_innovation_webcast/idle The webcast will also be available viaLinkedInandX (formerly known as Twitter) A very warm welcome! For further information, please contact: Per Lorentz, Vice President Corporate Communications, +46 73 313 30 55,per.lorentz@essity.comSandra Åberg, Vice President Investor Relations, +46 70 564 96 89,sandra.aberg@essity.com The following files are available for...
PR Newswire
27/11/2023
AB Science: The clinical development of masitinib in sickle cell disease is…
PRESS RELEASE THE CLINICAL DEVELOPMENT OF MASITINIB IN SICKLE CELL DISEASE, A HIGHLY PREVALENT GENETIC CONDITION, IS AMONG THE 19 WINNING PROJECTS UNDER THE SIXTH CALL FOR "HOSPITAL-UNIVERSITY RESEARCH IN HEALTH (RHU)".THIS PROGRAM WILL FUND A MASITINIB PHASE 2 CLINICAL TRIALAB SCIENCE WILL HOLD A WEBCAST ON THIS RESEARCH PROGRAM ON THURSDAY, NOVEMBER 30, 2023, FROM 3PM TO 4PM CETParis, November 27, 2023, 8am CETAB Science SA(Euronext - FR0010557264 - AB) announces today...
Nasdaq GlobeNewswire
27/11/2023
Groupe Casino: Communication by the Casino group
Communication by the Casino group Paris, 27 November 2023Following rumors in the press, the Casino group confirms that it has received preliminary expressions of interest for the acquisition of hypermarket and supermarket stores. These expressions of interest will be analyzed by the group and the consortium (EP Equity Investment III s.à.r.l, Fimalac and Trinity Investments Designated Activity Company) in the coming weeks, it being provided that any disposal shall be subject to the prior...
Nasdaq GlobeNewswire
27/11/2023
Press Release: Dupixent® significantly reduced COPD exacerbations in second…
Dupixent ®significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirming potential to become first approved biologic for this serious diseaseNOTUS trial met its primary endpoint with overwhelming efficacy, showing Dupixent significantly reduced exacerbations by 34% compared to placebo in patients with moderate-to-severe COPD with evidence of type 2 inflammation (ie, blood eosinophils ≥300 cells per μL), confirming results from...
Nasdaq GlobeNewswire
27/11/2023
Groupe Casino: Acquisition of GPA's stake in Cnova
Acquisition of GPA's stake in Cnova Paris, 27 November 2023Groupe Casino today announces the acquisition from GPA of CBD Luxembourg Holding, which indirectly holds 34.0% of Cnova's share capital (117,303,664 ordinary shares 1 ) ("the Transaction"). The Transaction will increase Casino's stake in Cnova, directly and through wholly-owned subsidiaries, to 98.8%.The purchase price has been set at €10,000,000 of which 80% is to be paid on completion of the Transaction, expected by 30...
Nasdaq GlobeNewswire
27/11/2023
Altri Comunicati